ProFlow (lipid emulsion based formulation of Prostaglandin E1) / SciClone, Taiwan Liposome Company - LARVOL DELTA

Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction. (PubMed, Heart Lung Circ) - "Ticagrelor treatment was associated with increased CFR in this high-risk population. Increased CFR may be a clinically important therapeutic effect of ticagrelor in addition to platelet inhibition."

Journal • Acute Coronary Syndrome • Cardiovascular • Coronary Artery Disease • Myocardial Infarction

ProFlow nano-liquid chromatography with a graphene oxide-functionalized monolithic nano-column for the simultaneous determination of chloramphenicol and chloramphenicol glucuronide in foods. (PubMed, J Food Sci) - "The use of new and advanced techniques is a crucial issue in the food science and technology. In this sense, this study demonstrated a new food analysis method using advanced instrumental technique with a homemade monolithic nano-column."

Journal • Infectious Disease

Open tubular nano-liquid chromatography with a new polylysine grafted on graphene oxide stationary phase for the separation and determination of casein protein variants in milk. (PubMed, J Chromatogr A) - "The developed OT column in the ProFlow nano-LC was applied to the separation of casein (CN) protein variants, including α-CN, α-CN, β-CN and Ƙ-CN...Several isoforms of α-CN could be detected. All results demonstrated that the developed OT column with a novel coating procedure was promising for advanced nano-liquid chromatographic separations."

Journal

Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease. (PubMed, Am J Physiol Heart Circ Physiol) - "The PROFLOW study consists of 220 patients with prior myocardial infarction and measured CFR with transthoracic echocardiography...Higher levels of MVs carrying an elevated concentration of proatherogenic proteins, circulate in plasma in patients with low CFR, a marker of vascular dysfunction, reduced blood flow and poor prognosis. Our findings demonstrate a potential clinical value of MVs as biomarkers and possible therapeutic targets against endothelial deterioration."

Clinical • Journal • Atherosclerosis • Cardiovascular • Dyslipidemia • Myocardial Infarction

"#FireHannity @MercedesBenz @mitsucars @Nutrisystem @optum @pcmatic @ProFlowers @pchdotcom @SandalsResorts" (@poseswim)

"@Hyundai @Optum @pcmatic @ProFlowers Consumer cellular Hisamitsu Pharmaceutical @HP (!!) NOOOOOO I use an HP laptop!" (@eamoncares)

"Hannity sponsors (cont)nNutrisystem @Nutrisystem nOptum @Optum nPC Matic @pcmatic nProFlowers @ProFlowers nPublishers Clearing House"

Biosimilar

"#GrabYourWallet NOT OK supporting Hannity’s twisted support for child molesters @terminix @AlfaRomeoUSA @hulu @CapitalOne @Hyundai @Nutrisystem @Casper @AngiesList @blinkhealth @Allstate @LibertyMutual @loanDepot @consumerplans @Optum @ProFlowers @bookingcom @exxonmobil @pcmatic" (@ZemanLynnZ)

Biosimilar

"#SeanHannity is a major douschebag and divider. Please stop supporting him NOW. @Allstate, @Bayer, @bookingcom, @CapitalOne, @hulu, @Hyundai, @JohnDeere, @ProFlowers, @SandalsResorts, @UNTUCKit, @AngiesList, @SharisBerries, @AstraZeneca, @exxonmobil, @hewlettpacka_dp." (@Doug_Bratman)

Biosimilar

"Looks like #BoycottHannityAdvertisers and #BoycottHannity are still going strong. n@bayer @untuckit @SharisBerries @ProFlowers"

Biosimilar

"@exxonmobil @Nutrisystem @hp @DIRECTV @hulu @vandapharma @Bayer @Optum @Charmin @AlfaRomeoUSA @ProFlowers @UNTUCKit @SharisBerries"

Biosimilar

"#SHAME on @MercedesBenz @mitsucars @Nutrisystem @Optum_Support @pcmatic @ProFlowers @TCHtweets @SandalsResorts @UNTUCKit @vandapharma"

Biosimilar

"@AstraZeneca @Bayer @bookingcom @Casper @HP @hulu @JennyCraig @JohnDeere @ProFlowers @SandalsResorts #FireHannity #StopHate"

Biosimilar

"@Nutrisystem @Optum @pcmatic @ProFlowers @SandalsResorts @SharisBerries @Terminix @UNTUCKit Please Stop Supporting " (@PinkyDoo08)

Biosimilar

PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve. (PubMed, Vasc Health Risk Manag) - "In this high-risk group of patients with prior MI, the prevalence of impaired CFR was high. Further risk stratification with CFR in addition to traditional cardiovascular risk factors may improve predictive accuracy for future MACE in this patient population."

Biomarker • Clinical • Journal